Find your next paid study

OHSU Knight Cancer InstituteNCT07844694

~$10 – $7,500

Myeloid MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes+2 more

A Telehealth Advance Care Planning Intervention for Older Patients With Myeloid Malignancies: A Pilot Randomized Controlled Trial

The objective of this project is to conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program …

University of RochesterNCT05875805

Phase 1

HM2023-05: GTB-3650 (Anti-CD16/IL-15/Anti-CD33) Tri-Specific Killer Engager (TriKE®) for the Treatment of High Risk Myelodysplastic Syndromes (MDS) and Refractory/Relapsed Acute Myeloid Leukemia (AML)

This is a Phase I dose finding study of GTB-3650 (anti-CD16/IL-15/anti-CD33) Tri-Specific Killer Engager (TriKE®) for the treatment of select CD33-expressing r…

Myeloid MalignancyAcute Myeloid LeukemiaMyelodysplastic Syndromes

Masonic Cancer Center, University of MinnesotaNCT06594445

Feasibility and Preliminary Efficacy of a Digital Story Intervention to Facilitate Decision-Making in Patients With Myeloid Cancers Considering Allogeneic Hematopoietic Cell Transplantation

This is a two-arm pilot randomized trial that assesses the feasibility and preliminary efficacy of a digital story and values clarification intervention (Consi…

Myeloid Malignancy

University of RochesterNCT07263074

Phase 1

A Phase I Trial to Evaluate the Safety and Efficacy of Addition of Novel Anti-leukemia Agents to Flu/Mel RIC Transplant for High-risk Myeloid Malignancies

The purpose of this study is to determine the safety of adding Decitabine and Venetoclax to patients undergoing reduced intensity allogenic transplantation for…

Myeloid MalignancyHematologic MalignancyAcute Myeloid Leukemia+1 more

University of Alabama at BirminghamNCT07044544

Phase 1

Phase 1B/2A Study of Weekly Decitabine and Venetoclax Treatment as Maintenance Therapy in High-Risk Myeloid Malignancy Patients Post Allograft Stem Cell Transplant

The goal of this interventional clinical trial is to determine if low doses of gentle chemotherapy after bone marrow transplant may prevent relapse and promote…

Myeloid MalignancyAcute Myeloid Leukemia

Benjamin TomlinsonNCT06129734

~$10 – $7,500

Myeloid MalignancyGenetic Predisposition to DiseaseMyeloid Hematological Malignancies

MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies

The goal of this research study is to evaluate the feasibility of germline genetic testing using the investigational MyeloGen Gene Panel in adult participants …

Christopher ReillyNCT07112287

~$10 – $7,500

Myeloid MalignancyInherited Bone Marrow Failure SyndromeClonal Expansion+10 more

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

This clinical trial tests next generation sequencing (NGS) for the detection of precursor features of pre-myeloid cancers and bone marrow failure syndromes. NG…

Advanced CancerSolid Tumor, AdultMyeloid Malignancy

Mayo ClinicNCT02958462

Molecular Services and EMR-Laboratory Integration Application (ELIA) for Reducing Leakage and Improving Healthcare Disparities in Cancer Patients

The goal of this observational study is to measure and try to reduce leakage in precision medicine care in the community cancer clinic. The goal of precision m…

Bien-Willner Physicians Group PANCT06090513

~$10 – $1,125

Phase 2

Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant

Previous studies provide a rationale for administration of AZA after allo SCT for decreasing chimerism. The investigators hypothesize that azacitidine can be w…

Myeloid Malignancy